Indian drug major Cipla's US plant cleared a routine USFDA cGMP inspection with zero Form 483...

Indian drug major Cipla's US plant cleared a routine USFDA cGMP inspection with zero Form 483 observations.

Preparing for cGMP audits? Zero Form 483 observations require no objectionable conditions in manufacturing processes, facilities, or controls.

https://manufacturing.economictimes.indiatimes.com/news/industry/cipla-subsidiary-clears-usfda-inspection-with-zero-observations/135138975